Ipsen Sa ADR (IPSEY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IPSEY | NBIX | IONS | ||
| Company | Ipsen Sa ADR | Neurocrine Bioscienc | Ionis Pharmaceuticals | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 46.5000 | 163.59 | 78.80 | ||
| High | 46.5000 | 169.56 | 82.63 | ||
| Low | 46.5000 | 163.12 | 78.80 | ||
| Latest | 46.5000 | 168.52 | 81.18 | ||
| Change | +1.1100 | +4.34 | +2.84 | ||
| % Change | +2.45% | +2.64% | +3.63% | ||
| Volume | 200 | 1,953,200 | 3,828,300 | ||
| 20-Day Average Volume | 1,885 | 1,270,005 | 1,953,985 | ||
| Previous Close | 45.3900 | 164.18 | 78.34 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 46.8213 | 161.86 | 75.01 | ||
| 20-Day Raw Stochastic | 41.76% | 93.23% | 86.33% | ||
| 20-Day Relative Strength | 52.96 | 63.26 | 64.76 | ||
| Weighted Alpha | +53.34 | +38.78 | +58.39 | ||
| Today's Opinion | 72% Buy | 88% Buy | 8% Buy | ||
| Previous Opinion | 72% Buy | 88% Buy | 8% Buy | ||
| Last Month's Opinion | 100% Buy | 56% Buy | 16% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.24% since 06/04/26 | +6.46% since 06/18/26 | +9.53% since 06/18/26 | ||
| Low | 43.6100 on 06/16/26 | 159.32 on 06/22/26 | 74.12 on 06/22/26 | ||
| High | 46.7500 on 06/08/26 | 169.56 on 06/26/26 | 82.63 on 06/26/26 | ||
| 1-Month | |||||
| %Chg | -4.63% since 05/15/26 | +8.21% since 05/26/26 | +6.72% since 05/26/26 | ||
| Low | 43.2022 on 06/02/26 | 154.05 on 06/02/26 | 72.02 on 06/03/26 | ||
| High | 47.2440 on 05/26/26 | 169.57 on 06/04/26 | 82.63 on 06/26/26 | ||
| 3-Month | |||||
| %Chg | +7.91% since 03/23/26 | +27.26% since 03/26/26 | +9.35% since 03/26/26 | ||
| Low | 43.2022 on 06/02/26 | 125.31 on 04/06/26 | 71.18 on 04/28/26 | ||
| High | 51.1000 on 05/05/26 | 169.57 on 06/04/26 | 82.63 on 06/26/26 | ||
| 6-Month | |||||
| %Chg | +33.09% since 12/22/25 | +16.01% since 12/26/25 | +1.56% since 12/26/25 | ||
| Low | 34.3400 on 01/05/26 | 122.14 on 02/12/26 | 68.90 on 03/24/26 | ||
| High | 51.1000 on 05/05/26 | 169.57 on 06/04/26 | 86.74 on 02/05/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 15,589,496 | 16,944,688 | 13,416,050 | ||
| Shares Outstanding, K | 335,258 | 100,550 | 165,263 | ||
| Annual Sales | 4,445,500,000 | 2,860,500,000 | 943,710,000 | ||
| Annual Net Income | 501,780,000 | 478,600,000 | -381,390,000 | ||
| Last Quarter Sales | N/A | 814,500,000 | 246,090,000 | ||
| Last Quarter Net Income | N/A | 197,900,000 | -92,530,000 | ||
| 60-Month Beta | 0.42 | 0.40 | 0.37 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 1.94 on 05/05/26 | -0.30 on 04/29/26 | ||
| Earnings Date | 02/12/26 | 07/29/26 | 07/29/26 | ||
| Most Recent Dividend | 0.300 on 06/04/26 | N/A | N/A | ||
| Next Ex-Dividends Date | 06/04/26 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 27.64 | 0.00 | ||